Key points are not available for this paper at this time.
The authors show that commercial tests for cobalamin levels provide false normal values in 22 to 35% of cases of pernicious anemia, the main disease they were designed to detect. The manufacturers need to solve the problem of interference of the assay by antibodies to intrinsic factor.
Carmel et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: